US/UK/Canada

Share

Contacts

  • Morten Henneveld

    CEO


    +46 18 55 39 93

    • Links

    Pick a time period -
    Tags ( Active)

    OssDsign to present Sirakoss acquisition via live Webcast

    OssDsign AB (publ) will be hosting a live webcast where CEO Morten Henneveld will present the previously communicated acquisition of Sirakoss Ltd.  The webcast, which will run from 10:00 CET today November 4th, can be followed via the link: https://www.finwire.tv/webcast/ossdsign/presentation/ For further information, please contact: Morten Henneveld, VD, OssDsign AB Tel: +46 73 382 43 90, email: morten.henneveld@ossdsign.com Certified Adviser:Erik Penser Bank AB is the company’s Certified Adviser. Contact information: Erik Penser Bank AB, Box 7405, 103 91 Stockholm, Sweden,

    OssDsign has carried out a directed share issue raising proceeds of approximately SEK 65 million to finance the Sirakoss acquisition

    The Board of Directors of OssDsign AB (publ) (”OssDsign” or the ”Company”) has, as communicated in the Company’s press release earlier today, resolved to carry out a directed share issue of 4,433,292 shares (corresponding to 25 percent of the total number of outstanding shares and votes in the Company) at a subscription price of SEK 14.70 per share (the “Directed Issue”). Due to the Directed Issue being heavily over-subscribed by a large number of Swedish and international investors, the gross proceeds in the Directed Issue were increased from the SEK 55 million indicated in the Company’s

    OssDsign acquires Sirakoss, enters USD 4 billion bone graft market

    OssDsign AB (publ) (“OssDsign”), a leading bone-regeneration company with headquarters in Uppsala, Sweden, today announces the signing of an agreement to acquire the privately held, Scottish bone graft specialist company Sirakoss Ltd (“Sirakoss”). The acquisition broadens OssDsign’s product portfolio with the 510(k) cleared Osteo[3] ZP Putty, a next-generation synthetic bone graft substitute for use in orthopaedic surgery. OssDsign acquires all outstanding Sirakoss shares in an all-cash transaction, which is subject to customary closing conditions. The purchase price of USD 11 million, not

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media